Hanns‐Martin Lorenz

493 total citations
19 papers, 278 citations indexed

About

Hanns‐Martin Lorenz is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Hanns‐Martin Lorenz has authored 19 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Hanns‐Martin Lorenz's work include Inflammasome and immune disorders (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Hanns‐Martin Lorenz is often cited by papers focused on Inflammasome and immune disorders (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Hanns‐Martin Lorenz collaborates with scholars based in Germany, Estonia and United States. Hanns‐Martin Lorenz's co-authors include Norbert Blank, Joachim R. Kalden, Birgit Köhler, Martin Bendszus, Wolfgang Wick, T Schaible, Corinna Seliger, Berit Jordan, Rainer H. Straub and Frieder Kees and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Arthritis Research & Therapy and The Lancet Respiratory Medicine.

In The Last Decade

Hanns‐Martin Lorenz

19 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanns‐Martin Lorenz Germany 9 76 74 74 68 54 19 278
Erhan Berber United States 5 92 1.2× 31 0.4× 62 0.8× 35 0.5× 39 0.7× 10 309
R. Bonometti Italy 8 28 0.4× 45 0.6× 49 0.7× 105 1.5× 152 2.8× 12 301
Maria Chiara Ditto Italy 10 74 1.0× 93 1.3× 124 1.7× 12 0.2× 35 0.6× 33 348
Ernesto Cairoli Uruguay 9 66 0.9× 74 1.0× 144 1.9× 28 0.4× 27 0.5× 31 285
Vitor Pordeus Brazil 5 78 1.0× 23 0.3× 73 1.0× 14 0.2× 36 0.7× 6 231
S. Turki Tunisia 9 30 0.4× 45 0.6× 80 1.1× 20 0.3× 21 0.4× 70 271
Yuebo Jin China 10 69 0.9× 35 0.5× 63 0.9× 14 0.2× 18 0.3× 42 234
María Martínez‐Urbistondo Spain 10 36 0.5× 20 0.3× 62 0.8× 33 0.5× 50 0.9× 27 193
Ana C Venhoff Germany 9 75 1.0× 53 0.7× 78 1.1× 14 0.2× 100 1.9× 15 331
Julia Ash United States 9 82 1.1× 21 0.3× 152 2.1× 17 0.3× 23 0.4× 16 317

Countries citing papers authored by Hanns‐Martin Lorenz

Since Specialization
Citations

This map shows the geographic impact of Hanns‐Martin Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanns‐Martin Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanns‐Martin Lorenz more than expected).

Fields of papers citing papers by Hanns‐Martin Lorenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanns‐Martin Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanns‐Martin Lorenz. The network helps show where Hanns‐Martin Lorenz may publish in the future.

Co-authorship network of co-authors of Hanns‐Martin Lorenz

This figure shows the co-authorship network connecting the top 25 collaborators of Hanns‐Martin Lorenz. A scholar is included among the top collaborators of Hanns‐Martin Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanns‐Martin Lorenz. Hanns‐Martin Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Merkt, Wolfgang, Manuel Röhrich, Eleni Mavriopoulou, et al.. (2025). Persisting CD19.CAR-T cells in combination with nintedanib: clinical response in a patient with systemic sclerosis-associated pulmonary fibrosis after 2 years. The Lancet Respiratory Medicine. 13(7). 651–654. 2 indexed citations
2.
Claus, Maren, Carsten Watzl, Philipp Kolb, et al.. (2024). Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case study. Arthritis Research & Therapy. 26(1). 211–211. 7 indexed citations
3.
Blank, Norbert, Ina Kötter, Marc Schmalzing, et al.. (2023). Clinical presentation and genetic variants in patients with autoinflammatory diseases: results from the German GARROD registry. Rheumatology International. 44(2). 263–271. 6 indexed citations
4.
Proft, Fabian, Diana Vossen, Xenofon Baraliakos, et al.. (2023). Befragung zu den Arbeits-, Weiterbildungs- und Forschungsbedingungen von Assistenzärztinnen und -ärzten in der internistisch-rheumatologischen Weiterbildung – BEWUSST. Zeitschrift für Rheumatologie. 83(4). 257–268. 2 indexed citations
5.
Kaulen, Leon D., Berit Jordan, Jan Purrucker, et al.. (2021). Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series. European Journal of Neurology. 29(2). 555–563. 76 indexed citations
6.
Grieshaber‐Bouyer, Ricardo & Hanns‐Martin Lorenz. (2020). Biosimilars – Chancen und Risiken. Der Internist. 61(5). 522–529. 3 indexed citations
7.
Haefeli, Walter E., Uta Merle, Hanns‐Martin Lorenz, et al.. (2020). A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19. Cytokine. 138. 155399–155399. 2 indexed citations
8.
Blank, Norbert & Hanns‐Martin Lorenz. (2019). Idiopathic Pericarditis—an Autoinflammatory Disease?. Current Rheumatology Reports. 21(5). 18–18. 7 indexed citations
9.
Köhler, Birgit, Hanns‐Martin Lorenz, & Norbert Blank. (2018). IL1-blocking therapy in colchicine-resistant familial Mediterranean fever. European Journal of Rheumatology. 5(4). 230–234. 27 indexed citations
10.
Aringer, Martin, Christoph Baerwald, Almut Meyer‐Bahlburg, et al.. (2016). Rheumatologie – Integration in die studentische Ausbildung (RISA). Zeitschrift für Rheumatologie. 75(5). 493–501. 16 indexed citations
11.
Näher, Helmut, et al.. (2010). Psoriatic arthritis: a review. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 8(5). 332–339. 22 indexed citations
12.
Wollenhaupt, J., Rieke Alten, M. Backhaus, et al.. (2009). Aktualisiertes Therapieschema der Rheumatoiden Arthritis. Ergebnisse eines Konsensusprozesses deutscher Rheumatologen 2009. Aktuelle Rheumatologie. 34(4). 234–239. 10 indexed citations
13.
Lorenz, Hanns‐Martin, Alexander H. Dalpke, Anthony D. Ho, et al.. (2008). Mycobacterium kansasii tenosynovitis in a rheumatoid arthritis patient with long‐term therapeutic immunosuppression. Arthritis Care & Research. 59(6). 900–903. 10 indexed citations
14.
Straub, Rainer H., Peter Härle, Martin Kriegel, Jürgen Schölmerich, & Hanns‐Martin Lorenz. (2005). Adrenal and Gonadal Hormone Variations during a Febrile Attack in a Woman with Tumor Necrosis Factor Receptor-Associated Periodic Syndrome. The Journal of Clinical Endocrinology & Metabolism. 90(10). 5884–5887. 1 indexed citations
15.
Kriegel, Martin, Ulrike Hüffmeier, Thomas Geiler, et al.. (2003). Tumor necrosis factor receptor–associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor: Implications for pathogenesis. Arthritis & Rheumatism. 48(8). 2386–2388. 31 indexed citations
16.
Straub, Rainer H., Georg Pongratz, Jürgen Schölmerich, et al.. (2003). Long‐term anti–tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion. Arthritis & Rheumatism. 48(6). 1504–1512. 45 indexed citations
17.
Lorenz, Hanns‐Martin. (2000). Biological agents: a novel approach to the therapy of rheumatoid arthritis. Expert Opinion on Investigational Drugs. 9(7). 1479–1490. 8 indexed citations
18.
Grünke, Mathias, Hanns‐Martin Lorenz, Thomas Hieronymus, et al.. (1997). In vivo blockade of TNF-α in patients with rheumatoid arthritis: Indication for tachyphylaxis in long term ex vivo and in vitro effects after repeated infusion of chimeric monoclonal antibody cA2. Immunology Letters. 56. 42–42. 2 indexed citations
19.
Lorenz, Hanns‐Martin. (1951). [Tonsiotren in therapy of chronic tonsillitis and tonsillary hyperplasia].. PubMed. 22(9). 247–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erhan Berber Breakdown of academic impact, for papers by R. Bonometti Breakdown of academic impact, for papers by Maria Chiara Ditto Breakdown of academic impact, for papers by Ernesto Cairoli Breakdown of academic impact, for papers by Vitor Pordeus Breakdown of academic impact, for papers by S. Turki Breakdown of academic impact, for papers by Yuebo Jin Breakdown of academic impact, for papers by María Martínez‐Urbistondo Breakdown of academic impact, for papers by Ana C Venhoff Breakdown of academic impact, for papers by Julia Ash
Rankless by CCL
2026